Category: Federal Forum Posters
Purpose: The risks of concomitant use of opioid analgesics and benzodiazepines are well documented. Patients receiving prescription opioids and benzodiazepines are at an increased risk for unintentional fatal overdose. A previous Veteran’s Administration study found that 27% of veterans who received opioids also received benzodiazepines, and about 50% of all drug overdose deaths occurred while receiving this combination.
The Memphis VAMC has made great strides in decreasing the number of patients on the combination of opioids and benzodiazepines. One of the methods used to decrease this combination is through the use of a pharmacy consult.
Methods: A retrospective analysis of computerized medical records from patients of the Memphis VAMC will be conducted. Patients taking both an opioid and benzodiazepine whose provider requested a pharmacy consult (via Prior Authorization Drug Request) will be analyzed. A SQL query will be performed to identify patients receiving concomitant opioids and benzodiazepines with a pharmacy consult via prior authorization drug request (PADR). Once patients are identified, medical records will be reviewed. Patients receiving Hospice care or in an inpatient status at the time of consult will be excluded. Baseline data including age, sex, race, dose of opioids and benzodiazepines, alternative therapies, length of taper, mental health visits, ER visits, and hospital visits will be assessed.
Results: not applicable
Conclusion: not applicable
Jessica Boh– PGY1 Pharmacy Practice Resident, Memphis VA Medical Center, Memphis, TN